Analysis of symposium articles on insulin pen devices and alternative insulin delivery methods

Journal of Diabetes Science and Technology

Volumn 4, Issue 3, 2010, Pages 558-561

  Dang, Devra K ^a   Lee, Jennifer ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b CVS Caremark   (United States)

Author keywords

Adherence; Insulin administration; Insulin pen; Insulin pump

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

DIABETES MELLITUS; DRUG SELF ADMINISTRATION; HUMAN; INSTRUMENTATION; METHODOLOGY; ORGANIZATION; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

CONGRESSES AS TOPIC; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; SELF ADMINISTRATION;

EID: 78349245624     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681000400308     Document Type: Conference Paper

References (11)

1. Selam J. Evolution of diabetes insulin delivery devices. J Diabetes Sci Technol. 2010;4(3):505-13.
2. Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther. 2006;28(10):1712-25; discussion 1710-1.
3. Cobden D, Lee WC, Balu S, Joshi AV, Pashos CL. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus. Pharmacotherapy. 2007;27(7):948-62. (Pubitemid 46986681)
4. Pearson TL. Practical aspects of insulin pen devices. J Diabetes Sci Technol. 2010;4(3):522-31.
5. Lee LJ, Anderson J, Foster SA, Corrigan SM, Smith DM, Curkendall S. Predictors of initiating rapid-acting insulin analog using vial/syringe, prefilled pen, and reusable pen devices in patients with type 2 diabetes. J Diabetes Sci Technol. 2010;4(3):547-57.
6. Williams AS, Schnarrenberger PA. A comparison of dosing accuracy: visually impaired and sighted people using insulin pens. J Diabetes Sci Technol. 2010;4(3):514-21.
7. Breslin SD, Ignaut DA, Boyd DE. Lessons learned during the development of HumaPen Memoir, an insulin pen with a memory feature. J Diabetes Sci Technol. 2010;4(3):540-6.
8. Zhang R, Jain S, Rowland M, Hussain N, Agarwal M, Gregoriadis G. Development and testing of solid dose formulations containing polysialic acid insulin conjugate: next generation of long-acting insulin. J Diabetes Sci Technol. 2010;4(3):532-9.
9. Lakshmanadoss U, Ayyappan S, Jain A, Konezny M, Rajamani K. The broken pen penalty. Diabetes Technol Ther. 2010;12(3):241-3.
10. Boronat M, Garcia-Delgado Y, Perez-Martin N, Novoa FJ. Severe deterioration of metabolic control caused by malfunction of a disposable insulin pen device. J Am Board Fam Med. 2008;21(6):575-6.
11. Reiher AE, Gallagher TA, Emanuele MA. Interference at work: a case report of a malfunctioning insulin pump. Endocrine. 2009;35(1):22-4.